| Literature DB >> 15298965 |
Jason W Barlow1, Marieke Mous, Joe C Wiley, Jennifer M Varley, Guillermina Lozano, Louise C Strong, David Malkin.
Abstract
Multiple early-onset tumors, frequently associated with germ line TP53 mutations characterize the Li-Fraumeni familial cancer syndrome (LFS). LFS-like (LFS-L) families have lower rates of germ line TP53 alteration and do not meet the strict definition of LFS. This study examined 7 LFS cell lines and 30 LFS and 36 LFS-L primary leukocyte samples for mutations in the proapoptotic p53-regulated gene BAX. No germ line BAX mutations were found. A known BAX polymorphism was observed, yet there was no correlation between polymorphism frequency and TP53 status in either LFS or LFS-L. In summary, alterations of BAX are not responsible for cancers in TP53 wild-type LFS or LFS-L families.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15298965
Source DB: PubMed Journal: Cancer Epidemiol Biomarkers Prev ISSN: 1055-9965 Impact factor: 4.254